PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 396.0
(0.51%)
IDR 396.0
(0.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 11418.56 Billion IDR | 3.67% |
| 2022 | 11014.7 Billion IDR | 4.62% |
| 2021 | 10528.32 Billion IDR | 0.68% |
| 2020 | 10457.14 Billion IDR | -4.41% |
| 2019 | 10939.95 Billion IDR | 79.23% |
| 2018 | 6103.96 Billion IDR | 73.23% |
| 2017 | 3523.62 Billion IDR | 50.51% |
| 2016 | 2341.15 Billion IDR | 70.37% |
| 2015 | 1374.12 Billion IDR | 18.76% |
| 2014 | 1157.04 Billion IDR | 36.51% |
| 2013 | 847.58 Billion IDR | 33.52% |
| 2012 | 634.81 Billion IDR | 17.18% |
| 2011 | 541.73 Billion IDR | -0.28% |
| 2010 | 543.25 Billion IDR | -4.24% |
| 2009 | 567.3 Billion IDR | 13.94% |
| 2008 | 497.9 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 11134.25 Billion IDR | -0.93% |
| 2024 Q3 | 11315.37 Billion IDR | -0.37% |
| 2024 Q1 | 11238.64 Billion IDR | -1.58% |
| 2023 FY | 11418.56 Billion IDR | 3.67% |
| 2023 Q4 | 11418.56 Billion IDR | 2.79% |
| 2023 Q3 | 11108.63 Billion IDR | -1.1% |
| 2023 Q2 | 11232.3 Billion IDR | 6.02% |
| 2023 Q1 | 10594.47 Billion IDR | -3.82% |
| 2022 Q1 | 10681.72 Billion IDR | 1.46% |
| 2022 Q4 | 11014.7 Billion IDR | -3.11% |
| 2022 FY | 11014.7 Billion IDR | 4.62% |
| 2022 Q2 | 11142.27 Billion IDR | 4.31% |
| 2022 Q3 | 11367.73 Billion IDR | 2.02% |
| 2021 Q2 | 10663.56 Billion IDR | 3.13% |
| 2021 FY | 10528.32 Billion IDR | 0.68% |
| 2021 Q1 | 10339.64 Billion IDR | -1.12% |
| 2021 Q4 | 10528.32 Billion IDR | -9.28% |
| 2021 Q3 | 11605.05 Billion IDR | 8.83% |
| 2020 Q4 | 10457.14 Billion IDR | -2.93% |
| 2020 FY | 10457.14 Billion IDR | -4.41% |
| 2020 Q3 | 10772.39 Billion IDR | 1.81% |
| 2020 Q2 | 10581.16 Billion IDR | 3.58% |
| 2020 Q1 | 10215.69 Billion IDR | -6.62% |
| 2019 Q4 | 10939.95 Billion IDR | 9.88% |
| 2019 FY | 10939.95 Billion IDR | 79.23% |
| 2019 Q1 | 8938.22 Billion IDR | 46.43% |
| 2019 Q2 | 8909.39 Billion IDR | -0.32% |
| 2019 Q3 | 9955.81 Billion IDR | 11.75% |
| 2018 Q2 | 5268.11 Billion IDR | 35.57% |
| 2018 FY | 6103.96 Billion IDR | 73.23% |
| 2018 Q1 | 3885.85 Billion IDR | 10.28% |
| 2018 Q4 | 6103.96 Billion IDR | 4.48% |
| 2018 Q3 | 5842.11 Billion IDR | 10.9% |
| 2017 Q3 | 3258.14 Billion IDR | 21.97% |
| 2017 Q2 | 2671.23 Billion IDR | 22.04% |
| 2017 Q1 | 2188.81 Billion IDR | -6.51% |
| 2017 FY | 3523.62 Billion IDR | 50.51% |
| 2017 Q4 | 3523.62 Billion IDR | 8.15% |
| 2016 Q3 | 1958.09 Billion IDR | 23.98% |
| 2016 Q4 | 2341.15 Billion IDR | 19.56% |
| 2016 Q1 | 1435.72 Billion IDR | 4.48% |
| 2016 Q2 | 1579.35 Billion IDR | 10.0% |
| 2016 FY | 2341.15 Billion IDR | 70.37% |
| 2015 Q2 | 1283.71 Billion IDR | 33.31% |
| 2015 Q1 | 962.96 Billion IDR | -16.77% |
| 2015 FY | 1374.12 Billion IDR | 18.76% |
| 2015 Q3 | 1369.15 Billion IDR | 6.66% |
| 2015 Q4 | 1374.12 Billion IDR | 0.36% |
| 2014 Q4 | 1157.04 Billion IDR | 12.59% |
| 2014 Q3 | 1027.65 Billion IDR | 8.16% |
| 2014 Q2 | 950.12 Billion IDR | 38.62% |
| 2014 Q1 | 685.42 Billion IDR | -19.13% |
| 2014 FY | 1157.04 Billion IDR | 36.51% |
| 2013 Q2 | 691.42 Billion IDR | 24.12% |
| 2013 Q4 | 847.58 Billion IDR | 6.36% |
| 2013 FY | 847.58 Billion IDR | 33.52% |
| 2013 Q3 | 796.86 Billion IDR | 15.25% |
| 2013 Q1 | 557.04 Billion IDR | -12.25% |
| 2012 Q3 | 699.47 Billion IDR | 17.24% |
| 2012 Q4 | 634.81 Billion IDR | -9.24% |
| 2012 Q1 | 535.74 Billion IDR | -1.11% |
| 2012 FY | 634.81 Billion IDR | 17.18% |
| 2012 Q2 | 596.59 Billion IDR | 11.36% |
| 2011 FY | 541.73 Billion IDR | -0.28% |
| 2011 Q4 | 541.73 Billion IDR | 0.0% |
| 2010 FY | 543.25 Billion IDR | -4.24% |
| 2009 FY | 567.3 Billion IDR | 13.94% |
| 2008 FY | 497.9 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 3658.01 Billion IDR | -212.152% |
| PT Itama Ranoraya Tbk | 599.68 Billion IDR | -1804.093% |
| PT Millennium Pharmacon International Tbk | 1361.96 Billion IDR | -738.386% |
| PT Soho Global Health Tbk | 2347.86 Billion IDR | -386.339% |